Trial updateRetina
Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4
Recruiting. Registered enrolment: 25. National Eye Institute (NEI)
Why it matters
Track this study through NCT04591483. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- —
- Registered enrolment
- 25
- Results posted
- No
- Sponsor
- National Eye Institute (NEI)
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.